Biomarker-Driven Analysis Using High-Throughput Approaches in Neuroinflammation and Neurodegenerative Diseases
- 1 January 2021
- book chapter
- Published by Springer Nature
- Vol. 1339, 51-58
Abstract
Aging is responsible for homeostatic dysregulation and the primary risk for neurodegenerative diseases. The main signaling pathways may regulate inflammatory-related disorders and neurodegeneration include genomic instability, cell senescence, and mitochondria dysfunction. The use of high-throughput technologies has emerged as a powerful approach to the rapid discovery of many candidate biomarkers for age-related diseases. Various types of molecules, such as nucleic acids, proteins, or metabolites, can serve as soluble factors in clinical practice with deviations in their normal biological levels being an indication of an underlying disease state. The development of multifactorial biomarkers based on models involving molecular alterations in complex disorders may also provide specific challenges for translating biological findings and targeted diagnostic tools. As diseases are often regulated by a multiset of markers that coordinate and interact each other in a complex signaling network to maintain holistic processes within a cell, potent network-based approaches to data-driven biomarker identification are required. System-based biomarker discovery pipelines can offer an extraordinary adjustment opportunity for data heterogeneity and limitation, whereas integrated analysis of distinct networks clusters can provide important information for the early detection of intracellular pathogenic processes as well as for monitoring the response to treatment.Keywords
This publication has 42 references indexed in Scilit:
- Alzheimer’s disease: A gas model. The NADPH oxidase–Nitric Oxide system as an antibubble biomachineryMedical Hypotheses, 2013
- Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brainFree Radical Biology and Medicine, 2013
- Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeuticsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- Dysregulation of Calcium Homeostasis in Alzheimer’s DiseaseNeurochemical Research, 2009
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Multiplex Ligation-Dependent Probe AmplificationThe Journal of Molecular Diagnostics, 2006
- Mechanisms of cytochrome c release from mitochondriaCell Death & Differentiation, 2006
- Are Peripheral Blood Cells From Patients With Alzheimer Disease More Sensitive to Apoptotic Stimuli?Alzheimer Disease & Associated Disorders, 2002
- Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction?Journal of Neuroimmunology, 2001